| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| b' Onur G\\xc3\\xb6k\\xc3\\xa7en, Merve Akku\\xc5\\x9. Neuroleptic Malignant Syndrome Concurrent with COVID-19 Infection: A Case Report. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 1. 2024-04-01. PMID:38556939.' |
keyword: covid-19, neuroleptic malignant syndrome, risperidone, antipsikotik, enfeksiyon. |
2024-04-01 |
2024-04-03 |
Not clear |
| David S Im, Marina Capitanov, Amy M VandenBer. Loxapine in the Treatment of Manic and Psychotic Symptoms in an Individual Intolerant to Multiple Mood-Stabilizing and Antipsychotic Medications. Case reports in psychiatry. vol 2023. 2023-06-19. PMID:37332889. |
during his inpatient psychiatric hospitalization, he experienced dress (drug reaction with eosinophilia and systemic symptoms) with valproate, nephrogenic diabetes insipidus with lithium, potential neuroleptic malignant syndrome with risperidone, and orthostasis/tachycardia with clozapine. |
2023-06-19 |
2023-08-14 |
Not clear |
| Patrick Vincent Marloth, Martin Riis Ladefoged, Magnus Spangsberg Boese. [Neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol]. Ugeskrift for laeger. vol 184. issue 45. 2022-11-08. PMID:36345898. |
[neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol]. |
2022-11-08 |
2023-08-14 |
Not clear |
| Patrick Vincent Marloth, Martin Riis Ladefoged, Magnus Spangsberg Boese. [Neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol]. Ugeskrift for laeger. vol 184. issue 45. 2022-11-08. PMID:36345898. |
this is a case report of a 27-year-old man who developed neuroleptic malignant syndrome after administration of olanzapine, risperidone and haloperidol. |
2022-11-08 |
2023-08-14 |
Not clear |
| Sibi Joseph, Jerry George, Mongezi Tau, Lourdes de Fatima Ibanez-Valdes, Thozama Dubula, Humberto Foyaca-Siba. Case Report: Neuroleptic malignant syndrome in a HIV-positive patient. F1000Research. vol 9. 2022-09-08. PMID:36072922. |
we report a 29-year-old, hiv-positive woman being treated with antipsychotic medication for psychosis (clopixol 200mg intramuscularly monthly, risperidone 2mg orally daily haloperidol 2.5mg twice a day), who presented with neuroleptic malignant syndrome. |
2022-09-08 |
2023-08-14 |
Not clear |
| Siddiqa Ozaal, Gaya Katuland. Exceptionally high creatine kinase levels in risperidone-induced neuroleptic malignant syndrome: A case report. SAGE open medical case reports. vol 10. 2022-03-21. PMID:35308054. |
risperidone is an atypical antipsychotic drug with anti-serotonergic and anti-dopaminergic properties which has a wide range of side effects, including neuroleptic malignant syndrome. |
2022-03-21 |
2023-08-13 |
Not clear |
| Müge Ayanoğlu, Elif Korgali, Taner Sezer, Halil Ibrahim Aydin, Fatma Müjgan Sönme. Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation. Brain & development. vol 42. issue 5. 2020-12-21. PMID:32173091. |
we describe the first child with guanidinoacetate methyltransferase (gamt) deficiency who developed neuroleptic malignant syndrome (nms) after the treatment of risperidone without elevated creatine kinase (ck) levels. |
2020-12-21 |
2023-08-13 |
Not clear |
| Anna Maria Szota, Izabela Radajewska, Przemysław Grudzka, Aleksander Araszkiewic. Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report. BMC psychiatry. vol 20. issue 1. 2020-12-21. PMID:32306929. |
neuroleptic malignant syndrome (nms) may be induced by atypical antipsychotic drugs (aapds) such as aripiprazole, olanzapine, risperidone and quetiapine, either as a single treatment or in combination with other drugs. |
2020-12-21 |
2023-08-13 |
Not clear |
| Michael Esang, Sabina Goldstein, Ravina Dham. The Role of Physical Examinations in Psychiatry as Illustrated in a Case of Neuroleptic Malignant Syndrome Versus Viral Encephalitis: A Case Report and Literature Review. Cureus. vol 11. issue 6. 2020-09-30. PMID:31410323. |
he had been taking risperidone 1 mg orally every 12 hours for two months. his primary treatment team suspected neuroleptic malignant syndrome (nms), but the consulting psychiatrist detected equivocal findings on physical examination and recommended a broader differential diagnosis. |
2020-09-30 |
2023-08-13 |
Not clear |
| Brian G Mitchell, Brady C McMahon, Candice W Mitchel. Neuroleptic Malignant Syndrome After Early Administration of Risperidone Long-Acting Injection. The primary care companion for CNS disorders. vol 19. issue 6. 2018-08-15. PMID:29195036. |
neuroleptic malignant syndrome after early administration of risperidone long-acting injection. |
2018-08-15 |
2023-08-13 |
Not clear |
| Scott Cherry, Dan Siskind, Valeria Spivak, Daniel Wysoczanski, Priyangika Halangod. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone? Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. vol 24. issue 6. 2018-02-12. PMID:27194777. |
fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone? |
2018-02-12 |
2023-08-13 |
Not clear |
| Kalliopi N Nikolaou, Rossetos Gournellis, Ioannis Michopoulos, Georgios Dervenoulas, Christos Christodoulou, Athanasios Douzeni. Neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome? Annals of general psychiatry. vol 14. 2015-11-20. PMID:26583039. |
neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome? |
2015-11-20 |
2023-08-13 |
Not clear |
| Kalliopi N Nikolaou, Rossetos Gournellis, Ioannis Michopoulos, Georgios Dervenoulas, Christos Christodoulou, Athanasios Douzeni. Neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome? Annals of general psychiatry. vol 14. 2015-11-20. PMID:26583039. |
the diagnosis of serotonin syndrome was challenging due to the relatively low dose of clomipramine, an increase of risperidone which had taken place before clomipramine administration and clinical symptoms which could be attributed to both serotonin and neuroleptic malignant syndrome. |
2015-11-20 |
2023-08-13 |
Not clear |
| C Weiss, J Santander, R Torre. Catatonia, neuroleptic malignant syndrome, and cotard syndrome in a 22-year-old woman: a case report. Case reports in psychiatry. vol 2013. 2013-10-04. PMID:24093068. |
the following case study describes a 22-year-old woman with depression and symptoms of psychosis who developed neuroleptic malignant syndrome after using risperidone, thus requiring life support equipment and bromocriptine, later recovering after seven days. |
2013-10-04 |
2023-08-12 |
Not clear |
| Toru Yamashita, Yasuo Fujii, Fuminari Misaw. Neuroleptic malignant syndrome associated with risperidone long-acting injection: a case report. Journal of clinical psychopharmacology. vol 33. issue 1. 2013-06-12. PMID:23288234. |
neuroleptic malignant syndrome associated with risperidone long-acting injection: a case report. |
2013-06-12 |
2023-08-12 |
Not clear |
| Eishi Motomura, Hisashi Tanii, Akihiro Usami, Keiko Ohoyama, Masanori Nakagawa, Motohiro Okad. Lamotrigine-induced neuroleptic malignant syndrome under risperidone treatment: a case report. The Journal of neuropsychiatry and clinical neurosciences. vol 24. issue 2. 2012-11-13. PMID:22772697. |
lamotrigine-induced neuroleptic malignant syndrome under risperidone treatment: a case report. |
2012-11-13 |
2023-08-12 |
Not clear |
| Po-Ren Teng, Hsien-Yuan Lan. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone. The Journal of neuropsychiatry and clinical neurosciences. vol 23. issue 4. 2012-05-10. PMID:22231327. |
emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone. |
2012-05-10 |
2023-08-12 |
Not clear |
| Shinichiro Ochi, Koichiro Kawasoe, Masao Abe, Ryuji Fukuhara, Kantaro Sonobe, Kentaro Kawabe, Shu-ichi Uen. A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation. General hospital psychiatry. vol 33. issue 6. 2012-03-09. PMID:21749835. |
a case study: neuroleptic malignant syndrome with risperidone and cyp2d6 gene variation. |
2012-03-09 |
2023-08-12 |
Not clear |
| Shinichiro Ochi, Koichiro Kawasoe, Masao Abe, Ryuji Fukuhara, Kantaro Sonobe, Kentaro Kawabe, Shu-ichi Uen. A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation. General hospital psychiatry. vol 33. issue 6. 2012-03-09. PMID:21749835. |
we present a schizophrenic patient who experienced neuroleptic malignant syndrome with risperidone treatment due to variants of the cyp2d6 gene with reduced function. |
2012-03-09 |
2023-08-12 |
Not clear |
| Ali Ertug Arslankoylu, Meryem Ozlem Kutuk, Cetin Okuyaz, Fevziye Toro. Neuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticus. Pediatric reports. vol 3. issue 3. 2011-11-10. PMID:22053263. |
neuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticus. |
2011-11-10 |
2023-08-12 |
Not clear |